Intrinsic Value of S&P & Nasdaq Contact Us

Roivant Sciences Ltd. ROIVW NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • GB • USD

SharesGrow Score
57/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Roivant Sciences Ltd. (ROIVW) has 18 known insider and institutional holders on record. The largest holder is Dexcel Pharma Technologies Ltd. with 102,849,443 shares. Other notable holders include SVF Investments (UK) Ltd and Sumitomo Chemical Co., Ltd..

ROIVW Insider Ownership

Top Holder
Dexcel Pharma Technologies Ltd.
102,849,443 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Dexcel Pharma Technologies Ltd. Director 102,849,443 2022-11-14
100%
2 Svf Investments (uk) Ltd 10 Percent Owner 73,031,667 2023-10-02
71%
3 Sumitomo Chemical Co., Ltd. 10 Percent Owner 71,251,083 2023-06-26
69%
4 Ramaswamy Vivek 10 Percent Owner 51,929,426 2024-01-03
50%
5 Manchester Keith S Director 5,023,787 2023-10-02
5%
6 Sukhatme Mayukh Pres&chief Investment Officer 1,306,889 2023-12-29
1%
7 Gline Matthew CEO 994,373 2023-12-29
1%
8 Viking Global Investors Lp 10 Percent Owner 641,010 2023-06-26
1%
9 Viking Global Performance Llc 10 Percent Owner 641,010 2023-06-26
1%
10 Venker Eric President & COO 544,584 2023-12-22
1%
11 Pulik Richard CFO 273,079 2023-12-29
0%
12 Qvt Financial Lp 10 Percent Owner 100,804 2023-10-02
0%
13 Gold Daniel Allen Director 100,804 2023-10-02
0%
14 Kumar Rakhi Chief Accounting Officer 87,126 2023-12-29
0%
15 Momtazee James C Director 75,456 2023-10-18
0%
16 Oren Ilan Director 74,976 2023-10-18
0%
17 Epperly Melissa B, Director 20,331 2023-10-18
0%
18 Fitzgerald Meghan Director 11,358 2023-10-18
0%

No ownership data available for ROIVW.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message